SOX9 and neoplasm: Expression levels of CTNNB1 (β-catenin) and SOX9, which is a transcriptional target of the β-catenin transcription factor complex (43), were plotted together with γδ T-cell density values determined by IHC from the same, matched tumor samples from the Scotland cohort.